-+ 0.00%
-+ 0.00%
-+ 0.00%

Harvard Bioscience Sees Q2 Sales $20.500M-$22.500M vs $21.900M Est

Benzinga·05/12/2026 11:34:47
Listen to the news
Harvard Bioscience (NASDAQ:HBIO) sees Q2 sales of $20.500 million-$22.500 million vs $21.900 million analyst estimate.